NCT05656287 My Mobile Wallet: An Intervention for Tuberculosis Medication Adherence in Rural Uganda
| NCT ID | NCT05656287 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mbarara University of Science and Technology |
| Condition | Tuberculosis |
| Study Type | INTERVENTIONAL |
| Enrollment | 242 participants |
| Start Date | 2022-04-14 |
| Primary Completion | 2025-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 242 participants in total. It began in 2022-04-14 with a primary completion date of 2025-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to develop My Mobile Wallet- a behavioral and economic intervention to support tuberculosis treatment adherence in rural southwestern Uganda. The main question\[s\] it aims to answer are: • Determine the optimal design and develop My Mobile Wallet as an intervention to support tuberculosis medication adherence • Assess the initial feasibility and acceptability of using My Mobile Wallet to support tuberculosis medication. Participants will use My Mobile Wallet intervention for a period of six months. Researchers will compare My Mobile Wallet intervention versus standard care to see if there is an impact on tuberculosis medication adherence.
Eligibility Criteria
Inclusion Criteria: * Newly diagnosed with TB per the clinic records (TB patients living with HIV will also be eligible) * Starting TB treatment now or been on TB treatment for \<2 weeks * Owning a mobile phone * Aged 18 years and older * Live in Mbarara District * Willing to grow hair on the head and to allow a small thatch of it/hair (10-25 strands/0.02 ng/mg) to be cut at month 2 and 4 in the study * Willing and able to give consent. Exclusion Criteria: * Unable to use mobile money-based SMS (train and test this skill at recruitment) * Severe mental condition limiting the ability to provide consent
Contact & Investigator
Angella Musiimenta, PhD
PRINCIPAL INVESTIGATOR
Mbarara University of Science and Technology
Frequently Asked Questions
Who can join the NCT05656287 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 100 Years, studying Tuberculosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05656287 currently recruiting?
Yes, NCT05656287 is actively recruiting participants. Contact the research team at amusiimenta@must.ac.ug for enrollment information.
Where is the NCT05656287 trial being conducted?
This trial is being conducted at Mbarara, Uganda.
Who is sponsoring the NCT05656287 clinical trial?
NCT05656287 is sponsored by Mbarara University of Science and Technology. The principal investigator is Angella Musiimenta, PhD at Mbarara University of Science and Technology. The trial plans to enroll 242 participants.